Thalidomide in Treating Patients With Gynecologic Sarcomas

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2000

Study Completion Date

August 31, 2006

Conditions
Endometrial CancerSarcoma
Interventions
DRUG

thalidomide

Trial Locations (10)

10011

St. Vincent's Comprehensive Cancer Center, New York

10016

NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York

10019

St. Luke's-Roosevelt Hospital Center - Roosevelt Division, New York

10021

New York Weill Cornell Cancer Center at Cornell University, New York

10029

Mount Sinai School of Medicine, New York

10461

Albert Einstein Clinical Cancer Center, The Bronx

10595

New York Medical College, Valhalla

11030

North Shore University Hospital, Manhasset

12208

Cancer Center of Albany Medical Center, Albany

53792-6164

University of Wisconsin Comprehensive Cancer Center, Madison

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

New York University Cancer Institute

OTHER

NCT00006005 - Thalidomide in Treating Patients With Gynecologic Sarcomas | Biotech Hunter | Biotech Hunter